Wellbutrin Offers Optimistic Case Study For Tysabri
The regulatory and commercial history of the antidepressant brand Wellbutrin may be one precedent for Biogen Idec and Elan to emulate in attempting to salvage the multiple sclerosis therapy Tysabri
The regulatory and commercial history of the antidepressant brand Wellbutrin may be one precedent for Biogen Idec and Elan to emulate in attempting to salvage the multiple sclerosis therapy Tysabri